Quercetin + Coenzyme Q10 for Metabolic Health
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to learn if Quercefit® or Ubiqsome™ can improve markers of healthy aging, blood sugar control, and heart health in older adults. It will also learn about the safety of these supplements.
The main questions it aims to answer are:
1. Do Quercefit® or Ubiqsome™ improve blood sugar, cholesterol, and markers of aging compared to a placebo?
2. What side effects, if any, do participants have while taking these supplements?
Researchers will compare Quercefit® (500 mg/day), Ubiqsome™ (300 mg/day), and a placebo (a look-alike capsule with no active ingredient).
Participants will:
1. Take their assigned capsules (Quercefit®, Ubiqsome™, or placebo) twice daily for 12 weeks
2. Go to a preferred clinic at the start and end of the study for a fasting blood draw
Complete at-home tests:
3. Grip strength testing (using a device mailed to them)
4. Online surveys about fatigue and quality of life
5. Report any side effects and keep track of supplement use
Who Is on the Research Team?
Jacob Wilson, PhD
Principal Investigator
The Applied Science and Performance Institute
Are You a Good Fit for This Trial?
This trial is for older adults who want to improve their blood sugar, cholesterol, and markers of healthy aging. People with prediabetes or concerns about metabolic health may be eligible. Those with serious medical conditions or allergies to the supplements likely cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants take Quercefit®, Ubiqsome™, or placebo capsules twice daily for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Quercefit®
- Ubiqsome™
Trial Overview
The study tests if Quercefit® (a form of quercetin) or Ubiqsome™ (a form of coenzyme Q10) can improve blood sugar, cholesterol, and signs of aging compared to a placebo. Participants take capsules twice daily for 12 weeks.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Placebo Group
500 mg Quercefit® per day, administered as one 250 mg capsule taken twice daily (morning and evening)
300 mg Ubiqsome™ per day, administered as one 150 mg capsule taken twice daily (morning and evening)
One placebo capsule taken twice daily (morning and evening)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Applied Science & Performance Institute
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.